Drug lookup
Drug reference

doxylamine succinate

Histamine H1 antagonist · Antiemetic

Histamine H1 antagonistAntiemeticATC R06AA09
CDSCO approvedATC R06AA09
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

Doxylamine succinate is a histamine H1 antagonist. When combined with pyridoxine, it effectively treats mild-to-moderate nausea and vomiting of pregnancy. Its exact antiemetic mechanism for pregnancy is not fully elucidated but involves antihistaminic properties.

Indications

Nausea and vomiting of pregnancy

Dosing

Adult
Initially, two delayed-release tablets (doxylamine 20 mg, pyridoxine 20 mg) at bedtime. May be increased to four tablets per day as needed (one morning, one afternoon, two bedtime).

Pharmacokinetics

Half-life
10 to 12 h
Metabolism
N-dealkylation in the liver
Excretion
In the urine

Side effects

Common
DrowsinessDry mouthLight-headednessConstipation

Related guidelines

Ask House about doxylamine succinate

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team